Copyright ©ERS Journals Ltd 2009 Taurolidine and oxidative stress: a rationale for local treatment of mesothelioma1 DISCAFF Dept and DFB Center, University of Piemonte Orientale "A. Avogadro", Novara, 4 Chest Medicine Unit, Brescia Hospital, Brescia, 5 Dept of Toxicology, University of Pavia, 6 Medical Oncology, IRCCS San Matteo University Hospital, Pavia, 7 Local Health Unit 11, Piemonte, Borgosesia, Italy. 2 Friedrich Mietscher Institute, Basel, Switzerland. 3 Lung Biology Center, SFGH, UCSF, San Francisco, CA, USA. 8 L. Mutti and G. Gaudino contributed equally to this work. CORRESPONDENCE: G. Gaudino, Dept of Chemical, Food, Pharmaceutical and Pharmacological Sciences and Drug and Food Biotechnology Center, University of Piemonte Orientale "A. Avogadro", Via Bovio 6, 28100 Novara, Italy. E-mail: giovanni.gaudino{at}unipmn.it Keywords: Akt, apoptosis, malignant mesothelioma, oxidative stress, taurolidine
Received: July 5, 2008
Malignant mesothelioma is an asbestos-related, aggressive tumour, resistant to most anticancer therapies. Akt is a key mediator of mesothelioma cell survival and chemoresistance. This study aimed to clarify the mechanism by which taurolidine (TN), a known synthetic compound with antimicrobial and antineoplastic properties, leads to mesothelioma cell death.
Apoptosis was studied by annexin V binding, cell cycle analysis, caspase-8 activation, poly(ADP-ribose) polymerase (PARP) cleavage and terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick-end labelling (TUNEL). Oxidative stress was measured by nitrite production and DNA oxidative damage. Protein expression and phosphorylation were evaluated by immunoprecipitation and immunoblotting.
TN induces cell death of mesothelioma cells, but not of non-neoplastic human mesothelial cells. After TN treatment of mesothelioma cells, Akt but not extracellular signal-regulated kinase (Erk) 1/2 activity is inhibited a in time- and dose-dependent manner. Protein phosphatase (PP)1
TN induces mesothelioma cell death via oxidative stress, accompanied by inhibition of Akt signalling. This provides a promising molecular rationale for TN as local treatment of malignant mesothelioma.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||